Y

YiChang HEC ChangJiang Pharmaceutical Co Ltd
HKEX:1558

Watchlist Manager
YiChang HEC ChangJiang Pharmaceutical Co Ltd
HKEX:1558
Watchlist
Price: 11.26 HKD -4.74% Market Closed
Updated: May 18, 2024

YiChang HEC ChangJiang Pharmaceutical Co Ltd
Income to Minority Interest

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

YiChang HEC ChangJiang Pharmaceutical Co Ltd
Income to Minority Interest Peer Comparison

Comparables:
H
3692
600436
600276
000538
S
688506

Competitive Income to Minority Interest Analysis
Latest Figures & CAGR of Competitors

Company Income to Minority Interest CAGR 3Y CAGR 5Y CAGR 10Y
Y
YiChang HEC ChangJiang Pharmaceutical Co Ltd
HKEX:1558
Income to Minority Interest
¥136.8m
CAGR 3-Years
306%
CAGR 5-Years
27%
CAGR 10-Years
N/A
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Income to Minority Interest
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Income to Minority Interest
-¥51.1m
CAGR 3-Years
-16%
CAGR 5-Years
N/A
CAGR 10-Years
-50%
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Income to Minority Interest
¥20.3m
CAGR 3-Years
25%
CAGR 5-Years
-6%
CAGR 10-Years
N/A
Yunnan Baiyao Group Co Ltd
SZSE:000538
Income to Minority Interest
-¥28.2m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
-40%
S
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
Income to Minority Interest
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is YiChang HEC ChangJiang Pharmaceutical Co Ltd's Income to Minority Interest?
Income to Minority Interest
136.8m CNY

Based on the financial report for Dec 31, 2023, YiChang HEC ChangJiang Pharmaceutical Co Ltd's Income to Minority Interest amounts to 136.8m CNY.

What is YiChang HEC ChangJiang Pharmaceutical Co Ltd's Income to Minority Interest growth rate?
Income to Minority Interest CAGR 5Y
27%

Over the last year, the Income to Minority Interest growth was 400%. The average annual Income to Minority Interest growth rates for YiChang HEC ChangJiang Pharmaceutical Co Ltd have been 306% over the past three years , 27% over the past five years .